Quarry LP’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$65.8K Buy
1,858
+490
+36% +$14.5K 0.01% 579
2026
Q1
$37.9K Buy
+1,368
New +$35.1K 0.01% 725
2025
Q2
Sell
-12,800
Closed -$129K 2004
2025
Q1
$129K Buy
+12,800
New +$138K 0.03% 423
2024
Q4
Sell
-7,500
Closed -$86.5K 1954
2024
Q3
$86.5K Buy
7,500
+2,500
+50% +$28.5K 0.02% 480
2024
Q2
$52.9K Buy
+5,000
New +$54.8K 0.02% 624

Other funds holding ROIV

Quarry LP's ROIV Position: Q2 2026 in Review

Quarry LP increased its Roivant Sciences (ROIV) stake by 36% in Q2 2026, buying an estimated $14.5K and bringing the position to 1,858 shares worth $65.8K. The position accounts for 0.01% of the portfolio, ranked #579.

Quarry LP first reported a position in ROIV in Q2 2024 and has held it in 5 quarters since. The position peaked at $129K in Q1 2025. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Quarry LP held 1,858 shares of Roivant Sciences worth $65.8K as of Q2 2026.
  • Quarry LP bought 490 Roivant Sciences shares in Q2 2026, an estimated $14.5K.
  • Roivant Sciences made up 0.01% of Quarry LP's portfolio in Q2 2026, its #579 holding.
  • Quarry LP first reported a position in Roivant Sciences in Q2 2024 and has held it in 5 quarters since.
  • Quarry LP's Roivant Sciences position peaked at $129K in Q1 2025.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.